Clinical Trial Update: Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with salvage chemotherapy for first-relapsed or refractory classical Hodgkin lymphoma; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Cologne | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: RECRUITING